Cargando…
Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19
The ongoing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has been a formidable global challenge. As yet, there are very few drugs to treat this infection and no vaccine is currently available. It has gradually become apparant that coronavirus disease 2019 (COVID-19) is not a...
Autores principales: | Zhang, Xuchang, Jiang, Man, Yang, Jianshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119437/ https://www.ncbi.nlm.nih.gov/pubmed/33965598 http://dx.doi.org/10.1016/j.ijid.2021.05.001 |
Ejemplares similares
-
Are circulating endothelial cells the next target for transcriptome-level pathway analysis in ARDS?
por: Costa Monteiro, Ana C., et al.
Publicado: (2023) -
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021) -
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
por: Bonaventura, Aldo, et al.
Publicado: (2021) -
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021) -
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
por: Olaimat, Amin N., et al.
Publicado: (2020)